Abstract

Emerging drug resistance in Salmonella Typhi and S. Paratyphi is a substantial public health concern. We report what appears to be the first case and isolation of multidrug resistant S. Paratyphi A carrying CTXM-15-type extended-spectrum beta-lactamase from a Japanese traveller returning from India.

Highlights

  • Emerging drug resistance in Salmonella Typhi and S

  • Paratyphi A producing CTX-M-15-type extended-spectrum beta-lactamase (ESBL) from a traveller returning from India

  • Enteric fever, including typhoid fever caused by S. enterica serotype Typhi

Read more

Summary

Rapid communications

Salmonella enterica serotype Paratyphi A carrying CTX-M-15 type extended-spectrum beta-lactamase isolated from a Japanese traveller returning from India, Japan, July 2013. Emerging drug resistance in Salmonella Typhi and S. Paratyphi A carrying CTXM-15-type extended-spectrum beta-lactamase from a Japanese traveller returning from India. Paratyphi A producing CTX-M-15-type extended-spectrum beta-lactamase (ESBL) from a traveller returning from India. To our knowledge, this is the first report of S. Enteric fever, including typhoid fever caused by S. enterica serotype Typhi Typhi) and paratyphoid fever caused by S. enterica serotype Paratyphi A Enteric fever is a common cause of fever in returned travellers [2]. Owing to the recent increase of fluoroquinolone resistance, third-generation cephalosporins, such as ceftriaxone or cefotaxime, have become the primary drugs for treatment of enteric fever [3]

Case report
Laboratory analyses
Patient treatment and outcome
Discussion and conclusion
Conflict of interest
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.